RETRANSMISSION: Defence Manufacturing Its Arm Vaccine in Preparation for Phase I Clinical Trial Against Solid Tumors streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
EQS-News: Defence Therapeutics Inc. / Key word(s): MiscellaneousDEFENCE MANUFACTURING ITS ARM VACCINE IN PREPARATION FOR PHASE I CLINICAL TRIAL AGAINST SOLID TUMORS 06.02.2023 / 08:00 CET/CESTThe issuer is solely responsible for the content of this announcement.CSE: DTC FSE: DTC  .
EQS-News: Defence Therapeutics Inc. / Key word(s): Miscellaneous DEFENCE MANUFACTURING ITS ARM VACCINE IN PREPARATION FOR PHASE I CLINICAL TRIAL AGAINST SOLID TUMORS 06.02.2023 / 08:00 CET/CEST The issuer is solely responsible for the content of this announcement. CSE: DTC FSE: DTC U.
03.02.2023 - EQS-News: Defence Therapeutics Inc. / Key word(s): Miscellaneous DEFENCE THERAPEUTICS AND CQDM FUND THE DEVELOPMENT OF A NEW CANCER VACCINE PLATFORM 03.02.2023 / 08:00 CET/CEST The issuer is solely responsible for the content of this announcement. . Seite 1
EQS-News: Defence Therapeutics Inc. / Key word(s): MiscellaneousDEFENCE THERAPEUTICS AND CQDM FUND THE DEVELOPMENT OF A NEW CANCER VACCINE PLATFORM 03.02.2023 / 08:00 CET/CESTThe issuer is solely responsible for the content of this announcement. CSE: DTC FSE: DTC.